A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma- A North Central Cancer Treatment Group Study, N057E

BACKGROUND: There is increasing evidence that paclitaxel and carboplatin are clinically active in the treatment of metastatic melanoma (MM). ABI-007 is an albumin bound formulation of paclitaxel which has demonstrated single agent activity against metastatic melanoma. METHODS: A parallel phase II tr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kottschade, Lisa A, Suman, Vera J., Amatruda, Thomas, McWilliams, Robert R., Mattar, Bassam I., Nikcevich, Daniel A, Behrens, Robert, Fitch, Tom R, Jaslowski, Anthony J, Markovic, Svetomir N
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3116030/
https://ncbi.nlm.nih.gov/pubmed/21472717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25659
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares